Trabectedin-pegylated liposomal doxorubicin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trabectedin-pegylated liposomal doxorubicin, covering 2022-09-23 to 2022-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma [Phase 2]